Accretion Nutraveda Limited IPO
FPSMEBSE00:00:00
Latest GMPGMP Updated 03 Feb 2026, 11:34
21
+16.28%
Accretion Nutraveda Limited IPO is a SME fixed price IPO. Issue size is ₹25 Cr. Price band is ₹122 to ₹129 per share. Minimum investment is ₹2.58 L. Lot size is 1000 shares. Open from 28 Jan 2026 to 30 Jan 2026. Allotment on 2 Feb 2026. Listing on 4 Feb 2026 at BSE. Managed by Sobhagya Capital Options Pvt.Ltd Registrar: Kfin Technologies Limited. Key details for GMP, subscription, price, allotment, and listing in one place.
Official documents:DRHP.
Accretion Nutraveda Limited IPO overview
Accretion Nutraveda Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Price band
₹122 to ₹129
Lot size
1000 shares / lot
Min investment
₹2,58,000
Issue open – close
28 Jan 2026 → 30 Jan 2026
Accretion Nutraveda Limited IPO important dates
Issue Opens
28 Jan 2026
Issue Closes
30 Jan 2026
Allotment
2 Feb 2026
Listing
4 Feb 2026
Accretion Nutraveda Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,58,000 |
| S-HNI (Min) | 3 | 3,000 | ₹3,87,000 |
| S-HNI (UPI) | 3 | 3,000 | ₹3,87,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,03,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,32,000 |
Cut‑off within the price band is set after book‑building when applicable. SME issues often require at least two lots; mainboard retail typically bids one lot at cut‑off.
Quick Profit Calculator for Accretion Nutraveda Limited IPO
Pre-filled: Issue Price = ₹129, Lot Size = 1,000 shares, Listing Price = ₹0
Profit based on the official listing price for each investor category.
About Accretion Nutraveda Limited IPO
From the company / RHP narrative.
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels.
The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.
Accretion Nutraveda Limited IPO Issue Objective
How the issuer plans to use IPO proceeds.
1 Purchase of Machineries for Automation in existing Manufacturing unit
2 Purchase of Machineries for New Manufacturing Setup
3 Funding working capital requirements of our company
4 General corporate purposes
Accretion Nutraveda Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.
What is Accretion Nutraveda Limited IPO?
Accretion Nutraveda Limited IPO is a public issue where the company offers its shares to investors through the stock exchange, allowing retail, HNI, and institutional participation.
What is the IPO price band of Accretion Nutraveda Limited IPO?
The IPO price band of Accretion Nutraveda Limited IPO is ₹₹122 to ₹129 per share, as mentioned in the issue details.
What is the minimum investment required for Accretion Nutraveda Limited IPO?
The minimum investment in Accretion Nutraveda Limited IPO is ₹2,58,000, based on the applicable lot size for retail investors.
What is the lot size of Accretion Nutraveda Limited IPO?
The lot size of Accretion Nutraveda Limited IPO is 1000 shares per lot, and applications must be made in multiples of this lot size.
What are the opening and closing dates of Accretion Nutraveda Limited IPO?
Accretion Nutraveda Limited IPO opens on 28 Jan 2026 and closes on 30 Jan 2026, as per the announced schedule.
What is Accretion Nutraveda Limited IPO subscription status?
Accretion Nutraveda Limited IPO subscription status shows the level of demand across retail, HNI, and institutional investor categories during the issue period.
What is Accretion Nutraveda Limited IPO GMP today?
Accretion Nutraveda Limited IPO GMP (Grey Market Premium) today is around ₹21, reflecting current grey market activity before listing.
Is Accretion Nutraveda Limited IPO GMP positive or negative?
Accretion Nutraveda Limited IPO GMP is currently subject to change, based on prevailing grey market trends. GMP may change over time.
What does Accretion Nutraveda Limited IPO GMP indicate for listing?
A positive Accretion Nutraveda Limited IPO GMP may indicate market interest ahead of listing, while actual listing performance depends on subscription response and market conditions.
When is Accretion Nutraveda Limited IPO listing date?
The expected listing date of Accretion Nutraveda Limited IPO is 4 Feb 2026, subject to completion of the allotment process.
Where can I check Accretion Nutraveda Limited IPO allotment status?
Accretion Nutraveda Limited IPO allotment status can be checked online once the allotment process is completed using application or PAN details.
Can Accretion Nutraveda Limited IPO subscription and GMP change before listing?
Yes, Accretion Nutraveda Limited IPO subscription figures and GMP may change during the issue period and before listing based on market activity.
Accretion Nutraveda Limited IPO Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Loading ratings…